drug
sugemalimab
Phase 2updated 3mo agoby CStone Pharmaceuticals Co Ltd
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying sugemalimab
- EP1Safety and Efficacy of NK510 to Treat NSCLC
- phase3Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
- phase2Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
- phase3A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that